CostantineAlbanyMD(He/Him)

PubMed

• 157 citations
  Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012
  Maha Hussain, Stephanie Daignault-Newton, Przemyslaw Twardowski, Costantine Albany, Mark N. Stein
  Journal of Clinical Oncology. 2017-12-20
• 13 citations
  Long-Term Survival of Good-Risk Germ Cell Tumor Patients After Postchemotherapy Retroperitoneal Lymph Node Dissection: A Comparison of BEP × 3 vs. EP × 4 and Treating ...
  Clint Cary, Joseph M. Jacob, Costantine Albany, Timothy A. Masterson, Nasser H. Hanna
  Clinical Genitourinary Cancer. 2017-10-16
• 83 citations
  Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
  Jörg Beyer, Laurence Collette, Nicolas Sauvé, Gedske Daugaard, Darren R. Feldman
  Journal of Clinical Oncology. 2021-03-17

Journal Articles

• Olanzapine for the Treatment of Advanced Cancer–Related Chronic Nausea and/or Vomiting  
  Rudolph M Navari, Costantine Albany, Charles L Loprinzi, JAMA Oncology
• Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration  
  Richard S Foster, Lawrence H Einhorn, Christopher J Sweeney, Guru Sonpavde, Costantine Albany, Chandra K Flack, The Journal of Urology
• Elevated serum creatinine at baseline predicts poor outcome in patients receiving cardiac resynchronization therapy  
  Shalaby A, El-Saed A, Voigt A, Albany C, Saba S, Pacing Clin Electrophysiol (PACE), 1/1/2008

Books/Book Chapters

• Hepatocellular Carcinoma 
  Chapter: Targeted Therapies for Hepatocellular Carcinoma. 
  Jonas W. Feilchenfeldt, Eileen M. O'Reilly, Costantine Albany and Ghassan K. Abou-Alfa2011
• Cancer Management: A Multidisciplinary Approach 
  Chapter: Testicular Cancer 
  Costantine Albany, Nasser H. Hanna, Patrick J. Loehrer, Atreya Dash, Mark K. Buyyounouski, Douglas SkareckyEdition 16th,

Abstracts/Posters

• Antitumor activity of brentuximab vedotin in CD30 positive refractory germ cell tumors.
  Costantine Albany, Darren Feldman, Lawrence Garbo, Lawrence Einhorn, GU ASCO, 1/1/2013
• A retrospective analysis of patients with intermediate risk germ cell tumor (IRGCT) treated at Indiana university from 2000-2010.
  Costantine Albany, Shailesh R. Satpute, Mary J. Brames, Yaman Suleiman, Nawar Al Nasrallah, Susan M. Perkins, Nasser H. Hanna, Lawrence H. Einhorn, ASCO, 1/1/2012
• Overall survival (OS) prognostic factors in metastatic castrate resistant prostate cancer (mCRPC) patients retreated with docetaxel (D).
  Shilpa Rashmikant Shah, Costantine Albany, Noah M. Hahn, ASCO, 1/1/2012

Lectures

• Clinical course of patients with cisplatin (CDDP)-associated neuropathy compared to other neurotoxic chemotherapy. 
  2019 ASCO Annual Meeting - 6/1/2019
• "Update on the Treatment of Prostate Cancer" 
  1/20/2013
• Grand Round: "Dissecting the molecular pathways of testicular germ cell tumor pathogenesis; from initiation to treatment resistance" 
  Indiana University Simon Cancer Center - 1/4/2013
• "Chemotherapy Induced Nausea and Vomiting (CINV)" 
  1/2/2013
• Join now to see all